- 1Department of Rheumatology & Immunology, Laboratory of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
- 2West China Lecheng Hospital, Sichuan University, Boao, Hainan, China
A Correction on
Neutrophils as key drivers of pulmonary fibrosis: unveiling mechanisms and therapeutic implications
By Liang X, Li Y, Tang Z, Luo Y and Liu Y (2025) Front. Immunol. 16:1718092. doi: 10.3389/fimmu.2025.1718092
There was a mistake in Figure 1 and Figure 2 as published. The content of Figure 1 and Figure 2 were erroneously switched. The corrected Figure 1 and Figure 2 appears below.
Figure 1. Diagram illustrating the roles of neutrophils in lung fibrosis across three stages: recruitment, activation, and fibrosis.
Figure 2. Neutrophil-centric crosstalk in lung fibrosis. The fibrotic process involves coordinated cellular interactions: (1) Macrophages, T cells, B cells and platelets recruit and activate neutrophils; (2) Activated neutrophils release NETs, NE, IL-1β, and TNF-α; (3) These effector molecules target lung epithelial and fibroblast cells, promoting apoptosis, EMT, and FMT to drive fibrosis. CXCL2, C-X-C motif chemokine ligand 2; VIP, vasoactive intestinal peptide; TGF-β1, transforming growth factor beta 1; IL-18, interleukin-18; IL-1β, interleukin-1 beta; C5a, complement component 5a; C5aR1, complement C5a receptor 1; GPV, glycoprotein V; CD40L, CD40 ligand; BAFF, B cell activating factor; IL-17A, interleukin-17A; NETosis, neutrophil extracellular trap formation; DNA, deoxyribonucleic acid; TNF-α, tumor necrosis factor alpha; IL-1β, interleukin-1 beta; MPO, myeloperoxidase; NE, neutrophil elastase; EMT, epithelial-mesenchymal transition; FMT, fibroblast-myofibroblasttransition.
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: pulmonary fibrosis, neutrophils, neutrophil extracellular traps, neutrophil elastase, crosstalk
Citation: Liang X, Li Y, Tang Z, Luo Y and Liu Y (2026) Correction: Neutrophils as key drivers of pulmonary fibrosis: unveiling mechanisms and therapeutic implications. Front. Immunol. 16:1761117. doi: 10.3389/fimmu.2025.1761117
Received: 05 December 2025; Accepted: 15 December 2025; Revised: 09 December 2025;
Published: 02 January 2026.
Edited and reviewed by:
Yuan Liu, Chinese Academy of Sciences, ChinaCopyright © 2026 Liang, Li, Tang, Luo and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yubin Luo, bHVveXViaW4yMDE2QDE2My5jb20=; Yi Liu, eWlsaXU4OTk5QHdjaHNjdS5jbg==
†These authors have contributed equally to this work